Presentation

An Open Label Dose Escalation Study to Evaluate the Safety of Administration of Non-Viral SDF-1 Plasmid to Treat Symptomatic Ischemic Heart Failure

Presenter: 195098|Marc Penn

February 20, 2013

REGISTER for free or LOG IN to view this content

An Open Label Dose Escalation Study to Evaluate the Safety of Administration of Non-Viral SDF-1 Plasmid to Treat Symptomatic Ischemic Heart Failure

Coronary

Factoid

Up Next

Presentation

Updates from the EURO CTO Club

Presenter: Alfredo Galassi

February 20, 2013

More slides +

Presentation

Canadian CTO Registry

Presenter: Bradley Strauss

February 20, 2013

Presentation

Introduction to the Hybrid Algorithm for CTO PCI

Presenter: Elliot Smith

February 20, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.